Powder: -20°C for 3 years | In solvent: -80°C for 1 year
R306465 is a novel HDAC inhibitor with broad-spectrum antitumor activity against solid (IC50: 30 to 300 nM) and hematological malignancies. R306465 was found to be a potent inhibitor of HDAC1 and -8 (class I) in vitro.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
500 μg | 35 days | $ 296.00 |
Description | R306465 is a novel HDAC inhibitor with broad-spectrum antitumor activity against solid (IC50: 30 to 300 nM) and hematological malignancies. R306465 was found to be a potent inhibitor of HDAC1 and -8 (class I) in vitro. |
Synonyms | Gemcitabine monophosphate disodium salt monohydrate, Gemcitabine monophosphate disodium, GemMP |
Molecular Weight | 343.18 |
Formula | C9H12F2N3O7P |
CAS No. | 116371-67-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: Soluble
H2O: Insoluble
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Gemcitabine monophosphate disodium salt 116371-67-6 Gemcitabine monophosphate disodium Monohydrate Gemcitabine monophosphate disodium salt monohydrate Gemcitabine Gemcitabine monophosphate disodium GemMP inhibitor inhibit